Navigation Links
AMD Alliance, Representing AMD Patient Organizations Globally, Encourages Health Care Providers to Stop Using Avastin for Off-Label Ocular Use
Date:10/19/2011

8;115:1911–1915
  • Austria (8 cases of severe eye inflammation were reported): Georgopoulos et al, Characteristics of severe intraocular inflammation following intravitreal injection of bevacizumab (Avastin). British Journal of Ophthalmology, 2009;93(4):457-462
  • Germany (5 cases of severe eye inflammation reported):  Statement available at http://wissen.spiegel.de/wissen/image/show.html?did=60666870&aref=image038/2008/09/27/ROSP200804001400141.PDF&thumb=false
  • Canada (105 cases of severe eye inflammation): Health Canada requested label update on Avastin to include warnings on unlicensed intravitreal use available at http://ophthalmologyrounds.ca/modules/contentManager/upload/document/alwaysOnLine/ScientificUpdate_en.pdf
  • China (61 cases of eye infection reported): Reported at http://www.chinadaily.com.cn/china/2010-09/24/content_11340951.htm
  • U.S. (12 cases of eye infection reported: FDA warning available at http://www.fda.gov/Drugs/DrugSafety/ucm270296.htm

  • (ii) FDA Alerts Health Care Professionals of Infection Risk from Repackaged AvastinIntravitreal Injections. Available at http://www.fda.gov/Drugs/DrugSafety/ucm270296.htm

    (iii) US Department of Veterans Affairs public statement.


    '/>"/>
    SOURCE AMDAI
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3

    Related medicine technology :

    1. OXIS International Assumes Control and Exploitation Rights to Key L-Ergothioneine Patent Filing Representing a Major Market Opportunity
    2. Investment in Oncology Drug Development Remains Strong as 133 Companies Initiate Late-Stage Clinical Trials Representing a 21% Increase
    3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
    4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
    5. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
    6. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
    7. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    8. Sixty-One Percent of Newly Diagnosed Parkinsons Disease Patients Do Not Receive Any Drug Treatment in the First Year of Diagnosis
    9. TaiGen Biotechnology Successfully Completes Patient Recruitment for Phase II Trial of Nemonoxacin for Treatment of Adult Community Acquired Pneumonia (CAP)
    10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    11. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:8/27/2015)... 2015  Hill-Rom Holdings, Inc., (NYSE: HRC ) ... the Morgan Stanley Global Healthcare Conference on September 16, ... invited to listen to the live discussion via the ... at https://cc.talkpoint.com/morg007/091615a_ae/?entity=49_UCJPU8N . A recorded replay ... the conclusion of the live event and accessible via ...
    (Date:8/27/2015)... The nation,s newest Actos trial gets underway Thursday, August 27 ... courtroom.  Attorneys representing two southern Nevada ... after using the diabetes drug Actos. "Takeda Pharmaceuticals ... that their drug Actos caused an increased risk of bladder ... hold Takeda responsible it is appropriate to seek substantial punitive ...
    (Date:8/27/2015)...  Mytrus, a technology and services company revolutionizing clinical trials, announced ... has received approval for use by Britain,s ... first time e-Consent technology will be used in a ... Mytrus was also the first electronic informed consent ... the U.S. Food and Drug Administration in 2011. It ...
    Breaking Medicine Technology:2 Billion Dollar Verdict Sought In Actos Trial 2Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 2Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 3Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 4Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 5Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 6Britain's National Health Service Approves The Use Of Mytrus Technology For Electronic Informed Consent In Clinical Trials 7
    ... , SAN DIEGO, Oct. 26 Horizon Therapeutics, ... an analysis from two pivotal Phase 3 trials ... HZT-501, a combination of ibuprofen with high-dose famotidine. ... risk factors for the development of non-steroidal anti-inflammatory ...
    ... Volcano Corporation (Nasdaq: VOLC ), a leader in ... and treatment of coronary and peripheral artery disease, today announced ... quarter and first nine months of fiscal 2009 on Thursday, ... to discuss its financial results and operating activities open to ...
    Cached Medicine Technology:Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 2Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 3Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users 4Volcano Corporation Schedules Third Quarter Conference Call, Webcast 2
    (Date:8/27/2015)... WILMINGTON, Del. (PRWEB) , ... August 27, 2015 , ... ... Hospital, will be the guest speaker at CURE® magazine’s 3rd Annual MPN Heroes™ ... , Dr. Arnold will be among hundreds of attendees honoring eight heroes who have ...
    (Date:8/27/2015)... ... August 27, 2015 , ... Healthpointe is proud to welcome ... Clinic in Los Angeles. Licensed to practice Chinese Needle Therapy since 1983, Dr. Priebe ... and diseases. Dr. Priebe also practices in Healthpointe’s La Mirada clinic and Garden Grove ...
    (Date:8/27/2015)... ... August 27, 2015 , ... Banc Intranets recently entered into ... will enable both Johnson City, Tenn.-based firms to work synergistically to promote similar products ... product that caters to organizations in the financial, commercial and services sectors. The software, ...
    (Date:8/27/2015)... ... August 27, 2015 , ... Florida Hospital North Pinellas, located at 1395 South Pinellas Avenue ... of 2016. The new facility will be located at US Highway 19 North and Highlands ... on August 18, and work on the project is slated to begin in September 2015. ...
    (Date:8/27/2015)... Downey, CA (PRWEB) , ... August 27, 2015 ... ... Oncology Institute of Hope and Innovation has grown to having twelve offices in ... in over 60 hospitals in the Southern California region. Founded by Dr. ...
    Breaking Medicine News(10 mins):Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 2Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 3Health News:Dr. Jennifer Arnold of ‘The Little Couple’ to Keynote 3rd Annual MPN Heroes™ Recognition Event in Orlando 4Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 2Health News:Qualified Medical Examiner and Acupuncturist Joins Healthpointe in Los Angeles 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 2Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 3Health News:Banc Intranets Forms Strategic Marketing Partnership with All Clear System 4Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 2Health News:Florida Hospital North Pinellas is Opening a New Free-Standing Emergency Room in Palm Harbor 3Health News:California’s Largest Private Oncology Practice Serves 50,000 Patients in 8 years 2
    ... to market ... final expense planning, HOUSTON, Nov. 3 ... SCI ) have formed a,unique partnership through SCI,s Dignity Memorial(TM) ... This is an extraordinary combination of services offered by two,industries ...
    ... Study: More Children Taking Medications for Blood Pressure, Cholesterol, ... Asthma, ADD/ADHD, Depression and Diabetes, ST. ... their use of type 2 diabetes medications between 2002 and,2005, ... a 166 percent,increase. One likely cause: Obesity, which is closely ...
    ... - Total revenue ... expanded to 32.4 percent from 28.5 percent ... - Net earnings: $0.8 million vs. $0.02 million - EPS: ... US: FIT), a leading provider of integrated,employee health and productivity management solutions, ...
    ... - Predictive medicine company,PreMD Inc. (TSX: PMD; PREMF.pk) today ... ("TSX") that it is reviewing the eligibility of the,Company,s ... The Company is being reviewed under the TSX,s Remedial ... with all requirements for continued,listing. If the Company cannot ...
    ... in stem cell research, experts say , , MONDAY, Nov. ... creating cloned mice from mouse bodies that had been ... feat may raise the specter of resurrecting lost species ... Teruhiko Wakayama said recreating woolly mammoths was "probably impossible." ...
    ... tissues in the intestinal tract that help protect the body ... immune cell newly identified by researchers at Washington University School ... immune cells could have a therapeutic role in inflammatory bowel ... Their report will appear in an upcoming issue of the ...
    Cached Medicine News:Health News:SLAICO and SCI Form Partnership 2Health News:Tweens and Teens Double Use of Diabetes Drugs 2Health News:Tweens and Teens Double Use of Diabetes Drugs 3Health News:Tweens and Teens Double Use of Diabetes Drugs 4Health News:HealthFitness Announces 2008 Third Quarter Results 2Health News:HealthFitness Announces 2008 Third Quarter Results 3Health News:HealthFitness Announces 2008 Third Quarter Results 4Health News:HealthFitness Announces 2008 Third Quarter Results 5Health News:HealthFitness Announces 2008 Third Quarter Results 6Health News:HealthFitness Announces 2008 Third Quarter Results 7Health News:HealthFitness Announces 2008 Third Quarter Results 8Health News:HealthFitness Announces 2008 Third Quarter Results 9Health News:HealthFitness Announces 2008 Third Quarter Results 10Health News:Listing Review initiated by the Toronto Stock Exchange 2Health News:Scientists Make Clones of Mice Dead 16 Years 2Health News:Previously unknown immune cell may help those with Crohn's and colitis 2
    ... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
    ... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    ... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
    Medicine Products: